Comparative proteomics analysis to annexin B1 DNA and protein vaccination in mice

Vaccine

Volumn 25, Issue 5, 2007, Pages 932-938

  Li, De An ^a   He, Ying ^a   Guo, Ying Jun ^a   Wang, Fang ^a   Song, Shu Xia ^a   Wang, Yue ^a   Yang, Fu ^a   He, Xiao Wen ^a   Sun, Shu Han ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Annexin B1; DNA vaccine; Proteomics

Indexed keywords

ANNEXIN; ANNEXIN B1; DNA VACCINE;

ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG MECHANISM; FEMALE; HISTOCOMPATIBILITY; IMMUNIZATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; T LYMPHOCYTE ACTIVATION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VACCINATION;

ANIMALS; ANNEXINS; ANTIBODIES, HELMINTH; BLOOD PROTEINS; FEMALE; HELMINTH PROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PROTEOMICS; T-LYMPHOCYTES; TAENIA SOLIUM; VACCINATION; VACCINES, DNA;

EID: 33845195533     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.08.042     Document Type: Article

References (24)

1. Garcia H.H., Evans C.A., Nash T.E., Takayanagui O.M., White Jr. A.C., Botero D., et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15 4 (2002) 747-756
2. Lightowlers M.W., Mitchell G.F., and Rickard M.D. Cestodes. In: Warren K.S. (Ed). Immunology and molecular biology of parasitic diseases. 3rd ed. (1992), Blackwell Scientific Publications, Boston 438-472
3. Huerta M., de Aluja A.S., Fragoso G., Toledo A., Villalobos N., Hernandez M., et al. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 20 1/2 (2001) 262-266
4. Toledo A., Fragoso G., Rosas G., Hernandez M., Gevorkian G., Lopez-Casillas F., et al. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Infect Immun 69 3 (2001) 1766-1773
5. Wang Q.M., Sun S.H., Hu Z.L., Wu D., and Wang Z.C. Immune response and protection elicited by DNA immunisation against Taenia cysticercosis. Vaccine 21 15 (2003) 1672-1680
6. Guo Y.J., Sun S.H., Zhang Y., Chen Z.H., Wang K.Y., Huang L., et al. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine. Vaccine 22 29/30 (2004) 3841-3847
7. Liu M.A. DNA vaccines: a review. J Intern Med 253 4 (2003) 402-410
8. Sun S.H., Wang J.X., Chen R.W., Lu H.P., Peng Y.C., and Wang Z.X. Molecular cloning of cDNA encoding immunodiagnostic antigens of cysticercosis. Chin J Parasitol Parasitic Dis 15 1 (1997) 15-20
9. Chambers G., Lawrie L., Cash P., and Murray G.I. Proteomics: a new approach to the study of disease. J Pathol 192 3 (2000) 280-288
10. Zhu H., Bilgin M., and Snyder M. Proteomics. Annu Rev Biochem 72 (2003) 783-812
11. Wang F., He X.W., Yan H.L., Huang J.J., Zhang Y., Jiang L., et al. Non-fusion expression in Escherichia coli: single-step purification of recombinant human annexin A5 for detection of apoptosis. Protein Expr Purif 45 1 (2006) 80-87
12. Shen H., Cheng G., Fan H., Zhang J., Zhang X., Lu H., et al. Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential. Proteomics 6 2 (2006) 528-537
13. Ahn K., Erlander M., Leturcq D., Peterson P.A., Fruh K., and Yang Y. In vivo characterization of the proteasome regulator PA28. J Biol Chem 271 30 (1996) 18237-18242
14. Song X., Mott J.D., von Kampen J., Pramanik B., Tanaka K., Slaughter C.A., et al. A model for the quaternary structure of the proteasome activator PA28. J Biol Chem 271 42 (1996) 26410-26417
15. Dubiel W., Pratt G., Ferrell K., and Rechsteiner M. Purification of an 11S regulator of the multicatalytic protease. J Biol Chem 267 31 (1992) 22369-22377
16. Kohda K., Ishibashi T., Shimbara N., Tanaka K., Matsuda Y., and Kasahara M. Characterization of the mouse PA28 activator complex gene family: complete organizations of the three member genes and a physical map of the approximately 150 kb region containing the alpha- and beta-subunit genes. J Immunol 160 10 (1998) 4923-4935
17. Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H., et al. A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381 6578 (1996) 166-168
18. Lueking A., Cahill D.J., and Mullner S. Protein biochips: a new and versatile platform technology for molecular medicine. Drug Discov Today 10 11 (2005) 789-794
19. Assuncao N.A., Deziderio L.A., Paulino L.G., Lupetti K.O., and Carrilho E. Nonaqueous capillary electrophoresis in coated capillaries: an interesting alternative for proteomic applications. Electrophoresis 26 17 (2005) 3292-3299
20. Sreekumar A., Nyati M.K., Varambally S., Barrette T.R., Ghosh D., Lawrence T.S., et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 61 20 (2001) 7585-7593
21. Edgar P.F., Schonberger S.J., Dean B., Faull R.L., Kydd R., and Cooper G.J. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry 4 2 (1999) 173-178
22. Woltjer R.L., Cimino P.J., Boutte A.M., Schantz A.M., Montine K.S., Larson E.B., et al. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. FASEB J 19 13 (2005) 1923-1925
23. Berhane B.T., Zong C., Liem D.A., Huang A., Le S., Edmondson R.D., et al. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 5 13 (2005) 3520-3530
24. Brotz-Oesterhelt H., Bandow J.E., and Labischinski H. Bacterial proteomics and its role in antibacterial drug discovery. Mass Spectrom Rev 24 4 (2005) 549-565